River Road Asset Management LLC Purchases New Shares in Smith & Nephew plc (NYSE:SNN)

River Road Asset Management LLC acquired a new position in Smith & Nephew plc (NYSE:SNN - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,239,187 shares of the medical equipment provider's stock, valued at approximately $38,588,000. River Road Asset Management LLC owned approximately 0.28% of Smith & Nephew as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in SNN. Janney Montgomery Scott LLC lifted its position in shares of Smith & Nephew by 13.8% in the first quarter. Janney Montgomery Scott LLC now owns 9,611 shares of the medical equipment provider's stock worth $244,000 after purchasing an additional 1,165 shares in the last quarter. Inspire Advisors LLC raised its position in Smith & Nephew by 4.7% during the first quarter. Inspire Advisors LLC now owns 21,647 shares of the medical equipment provider's stock worth $549,000 after acquiring an additional 970 shares in the last quarter. Headlands Technologies LLC raised its position in Smith & Nephew by 225.0% during the first quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider's stock worth $98,000 after acquiring an additional 2,666 shares in the last quarter. QRG Capital Management Inc. raised its position in Smith & Nephew by 47.0% during the first quarter. QRG Capital Management Inc. now owns 93,034 shares of the medical equipment provider's stock worth $2,359,000 after acquiring an additional 29,754 shares in the last quarter. Finally, Henry James International Management Inc. raised its position in Smith & Nephew by 12.2% during the first quarter. Henry James International Management Inc. now owns 205,417 shares of the medical equipment provider's stock worth $5,209,000 after acquiring an additional 22,341 shares in the last quarter. Institutional investors own 25.64% of the company's stock.

Analyst Ratings Changes

Several analysts have issued reports on the stock. StockNews.com raised shares of Smith & Nephew from a "buy" rating to a "strong-buy" rating in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research report on Friday.

Smith & Nephew Trading Up 1.1 %

Shares of SNN traded up $0.28 during trading hours on Tuesday, hitting $25.56. The company had a trading volume of 463,390 shares, compared to its average volume of 860,796. The business has a fifty day moving average of $29.75 and a 200-day moving average of $27.86. Smith & Nephew plc has a 12 month low of $23.65 and a 12 month high of $31.72. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.